Amgen AMGN
NASDAQ AMGN
$377.33 -5.14 (-1.34%)
As of: Sep 11, 2026 · 3:59 PM EDT

Amgen (AMGN) Intangibles (2009 - 2026)

Amgen (AMGN) posted Intangibles of $20.5 billion for Q2 2026, down 4.17% on a QoQ basis from $21.4 billion in Q1 2026, and down 16.77% year-over-year from $24.6 billion in Q2 2025.

Analysis

Amgen (AMGN) Intangibles (2009 - 2026) Analysis & Trends

Amgen has reported Intangibles for 18 years, with the latest figure at $20.5 billion in Q2 2026.

  • On a quarterly basis, Intangibles fell 16.77% year-over-year to $20.5 billion in Q2 2026; TTM through Jun 2026 was $20.5 billion, a 16.77% decrease from a year earlier, with the FY2025 full-year figure at $22.3 billion, down 19.58% from the prior year.
  • Intangibles was $20.5 billion for Q2 2026 at Amgen, down from $21.4 billion in the prior quarter.
  • The five-year high for Intangibles was $32.6 billion in Q4 2023, with the low at $13.2 billion in Q3 2023.
  • Average Intangibles over 5 years is $21.6 billion, with a median of $21.8 billion recorded in 2025.
  • The sharpest annual moves came in 2024 and 2025: Intangibles soared 119.92% in 2024, then declined 19.99% in 2025.
  • Over 5 years, Intangibles stood at $16.1 billion in 2022, then soared by 102.99% to $32.6 billion in 2023, then fell by 15.14% to $27.7 billion in 2024, then declined by 19.58% to $22.3 billion in 2025, then declined by 8.03% to $20.5 billion in 2026.
  • The last three Intangibles figures came in at $20.5 billion (Q2 2026), $21.4 billion (Q1 2026), and $22.3 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 20.49 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 14.03 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn 412.80 Mn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 1.31 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn 266.00 Mn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn 13.52 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -
10 Insmed 28.06 Bn 26.90 Bn 358.27 Mn 93.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.49 Bn
Mar 31, 2026 21.38 Bn
Dec 31, 2025 22.28 Bn
Sep 30, 2025 23.14 Bn
Jun 30, 2025 24.61 Bn
Mar 31, 2025 25.72 Bn
Dec 31, 2024 27.70 Bn
Sep 30, 2024 28.92 Bn
Jun 30, 2024 30.17 Bn
Mar 31, 2024 31.37 Bn
Dec 31, 2023 32.64 Bn
Sep 30, 2023 13.15 Bn
Jun 30, 2023 14.63 Bn
Mar 31, 2023 15.39 Bn
Dec 31, 2022 16.08 Bn
Sep 30, 2022 13.27 Bn
Jun 30, 2022 13.93 Bn
Mar 31, 2022 14.57 Bn
Dec 31, 2021 15.18 Bn
Sep 30, 2021 14.66 Bn